m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00004)
| Target Name | p-P70 | ||||
|---|---|---|---|---|---|
| Gene Name | p-P70 | ||||
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
p-P70
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Knockdown of METTL3 could obviously promote cell proliferation, migration and invasion function, and induce G0/G1 arrest,METTL3 acts as a novel marker for tumorigenesis, development and survival of RCC. Knockdown of METTL3 promoted changes in pI3K/AKT/mTOR markers' expression with a gain in p-PI3k, p-AKT, p-mTOR and p-P70, and a loss of p-4EBP1. | |||
| Target Regulation | Down regulation | |||
| Responsed Disease | Renal cell carcinoma | ICD-11: 2C90 | ||
| Cell Process | Epithelial-to-mesenchymal transition | |||
| Arrest cell cycle at G0/G1 phase | ||||
| In-vitro Model | ACHN | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 |
| Caki-1 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | |
| Caki-2 | Papillary renal cell carcinoma | Homo sapiens | CVCL_0235 | |
| HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
| In-vivo Model | Cells (5×106 cells in 200 uL) were suspended with 100 uL PBS and 100 uL Matrigel Matrix, and injected subcutaneously into the left armpit of each mouse. | |||
Renal cell carcinoma [ICD-11: 2C90]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Knockdown of METTL3 could obviously promote cell proliferation, migration and invasion function, and induce G0/G1 arrest,METTL3 acts as a novel marker for tumorigenesis, development and survival of RCC. Knockdown of METTL3 promoted changes in pI3K/AKT/mTOR markers' expression with a gain in p-PI3k, p-AKT, p-mTOR and p-P70, and a loss of p-4EBP1. | |||
| Responsed Disease | Renal cell carcinoma [ICD-11: 2C90] | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Down regulation | |||
| Cell Process | Epithelial-to-mesenchymal transition | |||
| Arrest cell cycle at G0/G1 phase | ||||
| In-vitro Model | ACHN | Papillary renal cell carcinoma | Homo sapiens | CVCL_1067 |
| Caki-1 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_0234 | |
| Caki-2 | Papillary renal cell carcinoma | Homo sapiens | CVCL_0235 | |
| HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
| In-vivo Model | Cells (5×106 cells in 200 uL) were suspended with 100 uL PBS and 100 uL Matrigel Matrix, and injected subcutaneously into the left armpit of each mouse. | |||